<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03307681</url>
  </required_header>
  <id_info>
    <org_study_id>REB2017-</org_study_id>
    <nct_id>NCT03307681</nct_id>
  </id_info>
  <brief_title>Effect of White Potatoes on Glycemic Response and Satiety in Children</brief_title>
  <official_title>Effect of White Potatoes on Glycemic Response and Satiety in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ryerson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ryerson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present study is to explore the influence of cooking methods on
      post-prandial glycaemia and its impact on satiety in children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Five treatments of (a) baked (with skin), (b) mashed (served hot and re-heated), (c) fried
      French fries, or (d) white bread prepared on the day of testing will be served to children
      (9-14 years). Participants will consume the equivalent to 1.5 medium sized potatoes (~250
      kcal) or white bread that will provide 50 g of available carbohydrates (defined as total
      carbohydrate minus dietary fiber). Glycemic response, insulin, incretin hormones
      glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP)), dipeptidyl
      peptidase 4 (DPP4), and cholecystokinin (CCK) will be measured for 2 h (0, 30, 60, 90 and 120
      min) following meal consumption, as well as mood and subjective appetite. An ad libitum test
      meal will be provided at 120 min to assess food intake suppression.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2018</start_date>
  <completion_date type="Anticipated">July 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ad libitum food intake (lunch, at 120 minutes)</measure>
    <time_frame>at 120 minutes post morning meal consumption</time_frame>
    <description>Food intake will be determined by weighing the meal before and after serving. The net weight of the test meal will be converted to calories</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline glycemic response</measure>
    <time_frame>30, 60, 90, and 120 minutes after meal consumption</time_frame>
    <description>Blood glucose (mmol/L). Blood glucose will be measured in whole blood using YSI 2300 STAT PLUS (YSI Incorporated, Yellow Springs, OH)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline insulin</measure>
    <time_frame>30, 60, 90, and 120 minutes after meal consumption</time_frame>
    <description>Blood insulin (pmol/L). Insulin concentration in serum will be determined in duplicate via enzyme-linked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline subjective appetite</measure>
    <time_frame>30, 60, 90, and 120 minutes after meal consumption</time_frame>
    <description>Measured using visual analogue scale (mm). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline mood</measure>
    <time_frame>30, 60, 90, and 120 minutes after meal consumption</time_frame>
    <description>Measured using visual analogue scale (mm). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline cholecystokinin (CCK)</measure>
    <time_frame>30, 60, 90, and 120 minutes after meal consumption</time_frame>
    <description>Blood CCK (pmol/L). CCK concentration in serum will be determined in duplicate via enzyme-linked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline dipeptidyl peptidase 4 (DPP4)</measure>
    <time_frame>30, 60, 90, and 120 minutes after meal consumption</time_frame>
    <description>Blood DPP4 (ng/mL). DPP4 concentration in serum will be determined in duplicate via enzyme-linked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline glucose-dependent insulinotropic peptide (GIP)</measure>
    <time_frame>30, 60, 90, and 120 minutes after meal consumption</time_frame>
    <description>Blood GIP (pmol/L). GIP concentration in serum will be determined in duplicate via enzyme-linked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline glucagon-like peptide-1 (GLP-1)</measure>
    <time_frame>30, 60, 90, and 120 minutes after meal consumption</time_frame>
    <description>Blood GLP-1 (pmol/L). GLP-1 concentration in serum will be determined in duplicate via enzyme-linked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>White bread</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test Meal (50 g of available carbohydrates)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Baked potato with skin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test Meal (50 g of available carbohydrates)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mashed potato served hot</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test Meal (50 g of available carbohydrates)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mashed potato re-heated</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test Meal (50 g of available carbohydrates)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fried French fries</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test Meal (50 g of available carbohydrates)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>White bread</intervention_name>
    <description>50 g of available carbohydrate meal</description>
    <arm_group_label>White bread</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Baked potato with skin</intervention_name>
    <description>50 g of available carbohydrate meal</description>
    <arm_group_label>Baked potato with skin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mashed potato served hot</intervention_name>
    <description>50 g of available carbohydrate meal</description>
    <arm_group_label>Mashed potato served hot</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mashed potato re-heated</intervention_name>
    <description>50 g of available carbohydrate meal</description>
    <arm_group_label>Mashed potato re-heated</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fried French fries</intervention_name>
    <description>50 g of available carbohydrate meal</description>
    <arm_group_label>Fried French fries</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  be between 9 and 14 years of age

          -  be healthy, and have been born at term

          -  be a native English speaker

          -  not be taking any medications

          -  not have allergies to potatoes, rice, or beans.

          -  normal body weight (between the 5th and 85th BMI percentile for age and gender)

        Exclusion Criteria:

          -  anyone with food sensitivities or allergies to potatoes or potato-products,

          -  smokers

          -  diabetic or overweight/obese individuals.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nick Bellissimo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ryerson University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nick Bellissimo, PhD</last_name>
    <phone>416-979-5000</phone>
    <phone_ext>3026</phone_ext>
    <email>nick.bellissimo@ryerson.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>School of Nutrition, Ryerson University</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 2K3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2017</study_first_submitted>
  <study_first_submitted_qc>October 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2017</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ryerson University</investigator_affiliation>
    <investigator_full_name>Nick Bellissimo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>White potatoes</keyword>
  <keyword>Children</keyword>
  <keyword>Satiety</keyword>
  <keyword>Glycaemia</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

